CNBC Special Report: How Soaring U.S. Drug Prices Fueled What Feds Call An Illegal Import Of Medications 11/27/25
Around the country, a pervasive question being asked: How can I afford my prescription drugs? The high cost of those medications, particularly very expensive drugs to treat serious diseases like multiple sclerosis and cystic fibrosis, have fueled a nationwide business in which insurance programs are using companies…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Meta’s Rally Keeps Rocking… And A Major AI Safety Warning 9/24/26
U.S. 10-Year Yield Hits 19-Year High… And The Ripple Effects From Meta’s Muse 9/23/26
Meta’s Muse Ripple Effects… And A Coiled Spring In Google 9/22/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
CNBC Special Report: Taking Stock 11/23/22
02.08.24 Rx Savings: The Quest Continues / To Employers: Enlightened Self-Interest
Best Buys, Overpriced Drugs, and Productivity Tips
Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.